+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Aortic Aneurysm Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 184 Pages
  • October 2025
  • Region: Global
  • 360iResearch™
  • ID: 5968010
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The aortic aneurysm market is undergoing significant transformation as innovative technologies and evolving regulatory frameworks increasingly impact competition, patient care, and resource management. Senior decision-makers require focused, up-to-date intelligence to effectively shape strategy and operational execution in a dynamic healthcare environment.

Aortic Aneurysm Market Snapshot

In 2024, the global aortic aneurysm market reached a value of USD 4.79 billion and is expected to increase to USD 5.22 billion by 2025. Projections for 2032 indicate the market may approach USD 9.53 billion, reflecting a compound annual growth rate (CAGR) of 8.97%. Expansion is being sustained by a greater reliance on minimally invasive endovascular procedures, continuous adjustments to surgical standards, and the widespread integration of advanced diagnostic and screening technologies. These advancing market dynamics are helping healthcare providers respond with earlier interventions and more efficient resource use, which benefit both operational outcomes and patient management. The steady adoption of leading technologies is timely for organizations addressing patient complexity and workflow optimization, positioning them well for future market shifts.

Scope & Segmentation: Strategic Insights for Leadership

Comprehensive segmentation of the aortic aneurysm market enables executives to focus on investments that best align clinical advancement and operational priorities. By understanding the full scope of treatment options, technology capabilities, patient demographics, and regional characteristics, decision-makers are well positioned to allocate resources and drive business growth according to emerging healthcare needs.

  • Treatment Modality: Evaluation of endovascular approaches, stent graft solutions, and open surgical interventions guides both clinical development and streamlining of internal processes for quality improvement.
  • Aneurysm Type: Category analysis of abdominal, thoracic, infrarenal, juxtarenal, suprarenal, ascending, descending, and thoracoabdominal aneurysms helps support organizational preparedness for a broad variety of complex cases.
  • End User: Assessment across hospitals, ambulatory surgery centers, and cardiology clinics assists with decisions on infrastructure development and workforce capabilities to support comprehensive care delivery.
  • Device Type: Focus on stent grafts and synthetic vascular grafts informs procurement and standardization to match contemporary clinical protocols and device standards.
  • Indication: Exploration of both elective procedures and emergency scenarios supports scenario-based capacity planning for routine and acute patient needs.
  • Patient Age Group: Insight into serving older populations as well as at-risk younger cohorts facilitates outreach and refined cohort management strategies.
  • Gender: Analysis of sex-specific clinical considerations encourages development of more inclusive pathways while addressing disparities within care models.
  • Regions: Intelligence spanning the Americas, Europe, Asia-Pacific, Middle East, and Africa promotes adaptation of products and practices to varied market and regulatory requirements.
  • Key Companies: Review of Medtronic plc, W. L. Gore & Associates, Cook Medical LLC, Endologix, Terumo Corporation, Lombard Medical, Jotec GmbH, Bolton Medical, Artivion, and MicroPort Scientific Corporation delivers context on industry innovation cycles and competitive dynamics.

Key Takeaways for Senior Decision-Makers

  • Device innovation and evolving surgical methods are increasing access and enabling organizations to close gaps in care for diverse patient populations.
  • Regional diversity in healthcare reimbursement and delivery systems means business strategies must adapt to distinct operational conditions and evolving compliance requirements.
  • Collaboration among manufacturers, providers, and regulators drives more seamless adoption of technology and improves readiness for upcoming procedural standards.
  • Granular market insights at the segment level provide the basis for more dynamic allocation of resources, with rapid adaptation to demographic trends or shifts in procedural volumes.
  • Wider use of advanced diagnostic and imaging tools strengthens patient tracking, minimizes delays in intervention, and boosts overall resource efficiency throughout the entire patient care process.

2025 United States Tariff Impact

Recent shifts in United States tariff policy have raised supply chain expenses and operational complexity for aortic aneurysm device manufacturers and suppliers. In response, sector leaders are re-evaluating sourcing relationships, building new domestic partnerships, and optimizing inventory management strategies to ensure reliable supply despite changing regulatory expectations. This environment places a premium on adaptability and proactive risk mitigation throughout the distribution chain.

Methodology & Data Sources

Findings in this analysis are produced through integrated reviews of clinical research, evaluation of regulatory changes, interviews with sector participants, and proprietary market studies. Supplementary insights are informed by detailed device utilization analytics. This thorough methodology underpins a nuanced assessment of present risks and future trends in the aortic aneurysm market.

Why This Report Matters

  • Empowers capital planning and supply chain management to secure procurement and maintain operational continuity through evolving market conditions.
  • Improves organizational agility by supporting rapid adoption of advanced medical solutions and service models.
  • Offers clear strategies for compliance, aiding in well-informed global or regional market entry and expansion decisions.

Conclusion

By leveraging the strategic insights in this analysis, leadership can fine-tune business direction, respond flexibly to ongoing industry change, and secure a strong market stance as the aortic aneurysm landscape progresses.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Surge in advanced endovascular aortic repair devices with integrated imaging guidance
5.2. Increasing adoption of artificial intelligence algorithms for aneurysm risk stratification and monitoring
5.3. Rising demand for minimally invasive hybrid procedures combining open and endovascular techniques
5.4. Growing investment in polymer coating technologies to enhance stent graft durability and biocompatibility
5.5. Expansion of telemedicine and remote patient monitoring for post-operative aortic aneurysm surveillance
5.6. Emergence of novel circulating biomarkers and liquid biopsy assays for aneurysm growth prediction
5.7. Focus on personalized genetic testing and precision medicine approaches in aneurysm risk management
5.8. Regulatory and reimbursement policy shifts accelerating approval and adoption of next-gen stent grafts
5.9. Rising incidence of aortic aneurysms in aging populations driving demand for preventive screening programs
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Aortic Aneurysm Market, by Treatment Modality
8.1. Endovascular Repair
8.1.1. Stent Graft
8.2. Open Surgical Repair
8.2.1. Biological Conduit
8.2.2. Synthetic Vascular Graft
9. Aortic Aneurysm Market, by Aneurysm Type
9.1. Abdominal Aortic Aneurysm
9.1.1. Infrarenal
9.1.2. Juxtarenal
9.1.3. Suprarenal
9.2. Thoracic Aortic Aneurysm
9.2.1. Ascending
9.2.2. Descending
9.2.3. Thoracoabdominal
10. Aortic Aneurysm Market, by End User
10.1. Ambulatory Surgery Centers
10.1.1. Cardiology Centers
10.1.2. Standalone Surgery Centers
10.2. Hospitals
10.2.1. General Hospitals
10.2.2. Specialized Vascular Centers
10.2.3. Tertiary Care Hospitals
11. Aortic Aneurysm Market, by Device Type
11.1. Stent Graft
11.2. Synthetic Vascular Graft
12. Aortic Aneurysm Market, by Indication
12.1. Elective Repair
12.2. Rupture Repair
13. Aortic Aneurysm Market, by Patient Age Group
13.1. 65 and Above
13.2. Under 65
14. Aortic Aneurysm Market, by Gender
14.1. Female
14.2. Male
15. Aortic Aneurysm Market, by Region
15.1. Americas
15.1.1. North America
15.1.2. Latin America
15.2. Europe, Middle East & Africa
15.2.1. Europe
15.2.2. Middle East
15.2.3. Africa
15.3. Asia-Pacific
16. Aortic Aneurysm Market, by Group
16.1. ASEAN
16.2. GCC
16.3. European Union
16.4. BRICS
16.5. G7
16.6. NATO
17. Aortic Aneurysm Market, by Country
17.1. United States
17.2. Canada
17.3. Mexico
17.4. Brazil
17.5. United Kingdom
17.6. Germany
17.7. France
17.8. Russia
17.9. Italy
17.10. Spain
17.11. China
17.12. India
17.13. Japan
17.14. Australia
17.15. South Korea
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Medtronic plc
18.3.2. W. L. Gore & Associates, Inc.
18.3.3. Cook Medical LLC
18.3.4. Endologix, Inc.
18.3.5. Terumo Corporation
18.3.6. Lombard Medical Inc.
18.3.7. Jotec GmbH
18.3.8. Bolton Medical Limited
18.3.9. Artivion, Inc.
18.3.10. MicroPort Scientific Corporation

Companies Mentioned

The companies profiled in this Aortic Aneurysm market report include:
  • Medtronic plc
  • W. L. Gore & Associates, Inc.
  • Cook Medical LLC
  • Endologix, Inc.
  • Terumo Corporation
  • Lombard Medical Inc.
  • Jotec GmbH
  • Bolton Medical Limited
  • Artivion, Inc.
  • MicroPort Scientific Corporation

Table Information